<?xml version="1.0" encoding="UTF-8"?>
<p id="para0033">Warren Capell reports research grants from Janssen Research and Development to CPC Clinical Research, during the conduct of the study; grants from Bayer Health Care to CPC Clinical Research, outside the submitted work. Elliot Barnathan is an employee of Janssen Research and Development, LLC, sponsor of the study, owns stock in the company, and reports a patent entitled "Prophylactic treatment of thrombotic events in outpatients" that is pending. Gregory Piazza reports grants from Janssen, during the conduct of the study; grants from BMS, grants from Bayer, grants from Portola, grants from BSC, outside the submitted work. Alex Spyropoulos reports grants and personal fees from Janssen, grants and personal fees from Boehringer Ingelheim, personal fees from BMS, personal fees from Bayer, personal fees from Portola, during the conduct of the study; personal fees from ATLAS Group, outside the submitted work. Judith Hsia reports grants from Janssen to CPC Clinical Research during protocol development. Scott Bull, Concetta Lipardi, Chiara Sugarmann, and Eunyoung Suh are employees of Janssen Research and Development LLC, during the conduct of the study and own stock in the company. Jaya Prakash Rao has nothing to disclose. William Hiatt reports grants from Janssen to CPC Clinical Research, but no payments to authors for work on the manuscript during the conduct of the study; grants from Northwell Health, outside the submitted work. Marc Bonaca reports grants from Janssen to CPC Clinical Research, during the conduct of the study; grants to CPC Clinical Research from Amgen, AstraZeneca, Bayer, Janssen, Merck, NovoNordisk, Pfizer, outside the submitted work.</p>
